NCT06907758 Impact of Perioperative Organ Resuscitation of Brain-dead Deceased Organ Donor on Kidney Graft Function in the Recipient
| NCT ID | NCT06907758 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Kidney Graft |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-04-10 |
| Primary Completion | 2025-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-04-10 with a primary completion date of 2025-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Brain-dead patients are the primary source of grafts for those awaiting organ transplantation. Recommendations exist for the management of these potential donors, based on the concept of organ resuscitation, according to which targeted resuscitation would improve graft quality and quantity. Graft performance thus depends on fixed factors (donor/recipient age, medical history, etc.) but also potentially modifiable factors. Through this study, the investigators aim to identify potentially modifiable factors in our donor care (in intensive care and the operating room) that may influence graft function in the recipient. For simplicity, the investigators will focus on kidney grafts. The aim is to improve the effectiveness of the transplant and reduce waiting times.
Eligibility Criteria
Inclusion Criteria: The inclusion criteria for organ donor patients are as follows: * Adult patient * Brain dead * Hospitalized in surgical intensive care at Strasbourg University Hospital (NHC cardiovascular intensive care unit, NHC multi-purpose intensive care unit, Hautepierre surgical intensive care unit) from January 1, 2018 to December 31, 2023 * Having undergone multi-organ transplantation * At least one of the donor kidneys has been transplanted to a patient at Strasbourg University Hospital * Absence of written objection in the medical file of the subject (and/or their legal representative, if applicable) to the reuse of their data for scientific research purposes. The inclusion criteria for kidney transplant recipients are as follows: * Adult patient * Recipient of a kidney transplant from an organ donor who meets the inclusion criteria for donor patients mentioned above * Patient who has undergone surgery and is hospitalized post-operatively at Strasbourg University Hospital * Patient monitored by the Strasbourg University Hospital transplant team * Absence of written objection in the subject's medical file (and/or their legal representative, if applicable) to the reuse of their data for scientific research purposes. Exclusion Criteria: * Subject (and/or their legal representative, if applicable) who has expressed their opposition to the reuse of their data for scientific research purposes * Brain-dead patient who has not undergone organ retrieval * Brain-dead patient whose kidney has not been allocated to a recipient in Strasbourg * Patient transferred to the Strasbourg University Hospital's intensive care unit from another hospital in a state of already diagnosed brain death solely for organ retrieval * Kidney transplant patient with a graft from a living donor * Kidney transplant patient with a graft from a deceased donor who is not brain-dead * Kidney transplant patient with a graft from a deceased donor who is brain-dead and hospitalized in a hospital other than Strasbourg
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06907758 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Graft. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06907758 currently recruiting?
Yes, NCT06907758 is actively recruiting participants. Contact the research team at charlotte.poussardin@chru-strasbourg.fr for enrollment information.
Where is the NCT06907758 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT06907758 clinical trial?
NCT06907758 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.